Angiotensin II raises blood pressure by vasoconstriction and increased aldosterone release. Direct action of angiotensin II on the vessel wall is mediated by binding to the G-protein-coupled angiotensin II receptor type 1 on vascular smooth muscle cells, which stimulates Ca2+/calmodulin-dependent phosphorylation of myosin and causes smooth muscle contraction.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
$substanceName is the active ingredient of these drugs:
Austria Estonia Ireland Lithuania Poland
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):